Eisbach Bio GmbH
PrivateLast Round
Grant
Nov 26, 2024
Total Funding Raised
$21.96M
Momentum Score
50 /100
Company Overview
Eisbach Bio GmbH is a biotechnology company developing novel drugs that target molecular vulnerabilities arising in cancer genomes.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Eisbach Bio GmbH Comps
Public and private peers based on sector, stage, and business model.
Eisbach Bio GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 26, 2024 | ||||
| VC Round | Mar 21, 2024 | ||||
| Grant | Nov 3, 2021 | ||||
| Grant | Jul 7, 2021 |
Key People
Founding team and executive leadership
Eisbach Bio GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bundesministerium für Bildung und Forschung | Grant |
| Cancer Focus Fund | VC Round |
| Cancer Prevention and Research Institute of Texas | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 19, 2026
Monthly visitors grew 78% MoM.
Eisbach Bio GmbH Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Eisbach Bio GmbH's valuation, stock price, and market status.
